COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 595: Articles 5941-5950  | Next

Effectiveness of BNT162b2 and CoronaVac against paediatric COVID-19-associated hospitalization and moderate-to-severe disease
Rosa Duque, J. S., Leung, D., Yip, K. M., Lee, D. H. L., So, H.-k., Wong, W. H. S., Lau, Y. L.
10.1101/2022.09.09.22279426 — Posted: 2022-09-09
Knowledge, Attitude and Practice (KAP) study on COVID-19 among the general population of Nepal.
Shrestha, S., Malla, R., Shrestha, S., Singh, P., Sherchand, J. B.
10.1101/2022.09.07.22279527 — Posted: 2022-09-09
Estimating the performance of mass testing strategies for COVID-19: a case study for Costa Rica
Solis, M., Pasquier, C., Nunez-Corrales, S., Madrigal-Redondo, G., Gatica-Arias, A.
10.1101/2022.09.05.22279618 — Posted: 2022-09-09
What is the long-term impact of COVID-19 on the Health-Related Quality of Life of individuals with mild symptoms (or non-hospitalised): A rapid review
Spencer, L. H., Hendry, A., Makanjuola, A., Davies, J., Pisavadia, K., Hughes, D. A., Fitzsimmons, D., Wilkinson, C., Edwards, R. T., Lewis, R., Cooper, A., Edwards, A. G.
10.1101/2022.09.09.22279642 — Posted: 2022-09-09
Impact of the COVID-19 pandemic on tuberculosis notification in Brazil
Pelissari, D. M., Batholomay, P., Johansen, F. D. C., Diaz-Quijano, F. A.
10.1101/2022.09.05.22279616 — Posted: 2022-09-09
Psychological factors associated with reporting side effects following COVID-19 vaccination: a prospective cohort study (CoVAccS - wave 3)
Smith, L. E., Sim, J., Sherman, S. M., Amlot, R., Cutts, M., Dasch, H., Sevdalis, N., Rubin, J.
10.1101/2022.09.07.22279682 — Posted: 2022-09-09
The effects of COVID-19 on child mental and social health: biannual assessments up to April 2022 in a clinical and two general population samples
Zijlmans, J., Tieskens, J. M., van Oers, H. A., Alrouh, H., Luijten, M. A., de Groot, R., van der Doelen, D., Klip, H., van der Lans, R. M., de Meyer, R., van der Mheen, M., Ruisch, H. I., van den Berg, G., Bruining, H., Buitelaar, J., van der Rijken, R., Hoekstra, P. J., Kleinjan, M., Lindauer, R. J., Oostrom, K. J., Staal, W., Vermeiren, R., Cornet, R., Haverman, L., Popma, A., Bartels, M., Polderman, T.
10.1101/2022.09.08.22279670 — Posted: 2022-09-09
Are primary care virtual visits associated with higher emergency department use? A cross-sectional analysis from Ontario, Canada
Kiran, T., Green, M. E., Strauss, R., Wu, C. F., Daneshvarfard, M., Kopp, A., Lapointe-Shaw, L., Latifovic, L., Frymire, E., Glazier, R. H.
10.1101/2022.09.08.22278709 — Posted: 2022-09-09
SARS-CoV-2 seroprevalence on the north coast of Peru: A cross-sectional study after the first wave
Moyano, L. M., Toledo, A. K., Chirinos, J., Vilchez Barreto, P. M. Q., Cavalcanti, S., Gamboa, R., Ypanaque, J., Meza, M., Noriega, S., Herrera, V., Bazan, E., Requena, A., Silva, H., Burgos, H., Leon-Jimenez, F., Group of Neuroepidemiology and Science of Life of Peru
10.1101/2022.09.07.22279669 — Posted: 2022-09-09
Genomic epidemiology of SARS-CoV-2 infections in The Gambia, March 2020 to Jan 2022
Kanteh, A., Jallow, H. S., Manneh, J., Sanyang, B., Kujabi, M. A., Ndure, S. L., Jarju, S., Sey, A. P., Damilare, D. K., Bah, Y., Sambou, S., Jarju, G., Manjang, B., Jagne, A., Bittaye, S. O., Bittaye, M., Forrest, K., Tiruneh, D. A., Samateh, A. L., Jagne, S., Hue, S., Mohammed, N., Amambua-Ngwa, A., Kampmann, B., D'Alessandro, U., de Silva, T. I., Roca, A., Sesay, A. K.
10.1101/2022.09.07.22278739 — Posted: 2022-09-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).